788 related articles for article (PubMed ID: 8553070)
21. Characterization of a newly established human pancreatic carcinoma cell line, UK Pan-1.
Fralix KD; Ahmed MM; Mattingly C; Swiderski C; McGrath PC; Venkatasubbarao K; Kamada N; Mohiuddin M; Strodel WE; Freeman JW
Cancer; 2000 May; 88(9):2010-21. PubMed ID: 10813711
[TBL] [Abstract][Full Text] [Related]
22. Status of the DPC4 tumor suppressor gene in sporadic colon adenocarcinoma of Croatian patients: identification of a novel somatic mutation.
Popović Hadzija M; Radosevic S; Kovacević D; Lukac J; Hadzija M; Spaventi R; Pavelić K; Kapitanović S
Mutat Res; 2004 Apr; 548(1-2):61-73. PubMed ID: 15063137
[TBL] [Abstract][Full Text] [Related]
23. No SMAD4 hypermethylation in colorectal cancer.
Roth S; Laiho P; Salovaara R; Launonen V; Aaltonen LA
Br J Cancer; 2000 Oct; 83(8):1015-9. PubMed ID: 10993648
[TBL] [Abstract][Full Text] [Related]
24. Nuclear localization of Dpc4 (Madh4, Smad4) in colorectal carcinomas and relation to mismatch repair/transforming growth factor-beta receptor defects.
Montgomery E; Goggins M; Zhou S; Argani P; Wilentz R; Kaushal M; Booker S; Romans K; Bhargava P; Hruban R; Kern S
Am J Pathol; 2001 Feb; 158(2):537-42. PubMed ID: 11159190
[TBL] [Abstract][Full Text] [Related]
25. Homozygous deletion map at 18q21.1 in pancreatic cancer.
Hahn SA; Hoque AT; Moskaluk CA; da Costa LT; Schutte M; Rozenblum E; Seymour AB; Weinstein CL; Yeo CJ; Hruban RH; Kern SE
Cancer Res; 1996 Feb; 56(3):490-4. PubMed ID: 8564959
[TBL] [Abstract][Full Text] [Related]
26. Involvement of mutations in the DPC4 promoter in endometrial carcinoma development.
Zhou Y; Kato H; Shan D; Minami R; Kitazawa S; Matsuda T; Arima T; Barrett JC; Wake N
Mol Carcinog; 1999 May; 25(1):64-72. PubMed ID: 10331746
[TBL] [Abstract][Full Text] [Related]
27. DCC and SMAD4 alterations in human colorectal and pancreatic tumor dissemination.
Tarafa G; Villanueva A; Farré L; Rodríguez J; Musulén E; Reyes G; Seminago R; Olmedo E; Paules AB; Peinado MA; Bachs O; Capellá G
Oncogene; 2000 Jan; 19(4):546-55. PubMed ID: 10698524
[TBL] [Abstract][Full Text] [Related]
28. New tumor suppressor found in pancreatic cancer.
O'Brien C
Science; 1996 Jan; 271(5247):294. PubMed ID: 8553063
[No Abstract] [Full Text] [Related]
29. Somatic alterations of the DPC4 gene in human colorectal cancers in vivo.
Takagi Y; Kohmura H; Futamura M; Kida H; Tanemura H; Shimokawa K; Saji S
Gastroenterology; 1996 Nov; 111(5):1369-72. PubMed ID: 8898652
[TBL] [Abstract][Full Text] [Related]
30. Loss of DPC4 expression and its correlation with clinicopathological parameters in pancreatic carcinoma.
Hua Z; Zhang YC; Hu XM; Jia ZG
World J Gastroenterol; 2003 Dec; 9(12):2764-7. PubMed ID: 14669329
[TBL] [Abstract][Full Text] [Related]
31. Disruption of the antiproliferative TGF-beta signaling pathways in human pancreatic cancer cells.
Villanueva A; García C; Paules AB; Vicente M; Megías M; Reyes G; de Villalonga P; Agell N; Lluís F; Bachs O; Capellá G
Oncogene; 1998 Oct; 17(15):1969-78. PubMed ID: 9788440
[TBL] [Abstract][Full Text] [Related]
32. Molecular analyses of the 15q and 18q SMAD genes in pancreatic cancer.
Jonson T; Gorunova L; Dawiskiba S; Andrén-Sandberg A; Stenman G; ten Dijke P; Johansson B; Höglund M
Genes Chromosomes Cancer; 1999 Jan; 24(1):62-71. PubMed ID: 9892110
[TBL] [Abstract][Full Text] [Related]
33. DPC4, a candidate tumor suppressor gene, is altered infrequently in head and neck squamous cell carcinoma.
Kim SK; Fan Y; Papadimitrakopoulou V; Clayman G; Hittelman WN; Hong WK; Lotan R; Mao L
Cancer Res; 1996 Jun; 56(11):2519-21. PubMed ID: 8653689
[TBL] [Abstract][Full Text] [Related]
34. MADR2 maps to 18q21 and encodes a TGFbeta-regulated MAD-related protein that is functionally mutated in colorectal carcinoma.
Eppert K; Scherer SW; Ozcelik H; Pirone R; Hoodless P; Kim H; Tsui LC; Bapat B; Gallinger S; Andrulis IL; Thomsen GH; Wrana JL; Attisano L
Cell; 1996 Aug; 86(4):543-52. PubMed ID: 8752209
[TBL] [Abstract][Full Text] [Related]
35. Mutations of the DPC4/Smad4 gene in neuroendocrine pancreatic tumors.
Bartsch D; Hahn SA; Danichevski KD; Ramaswamy A; Bastian D; Galehdari H; Barth P; Schmiegel W; Simon B; Rothmund M
Oncogene; 1999 Apr; 18(14):2367-71. PubMed ID: 10327057
[TBL] [Abstract][Full Text] [Related]
36. Tumor suppressor gene Smad4/DPC4, its downstream target genes, and regulation of cell cycle.
Chiao PJ; Hunt KK; Grau AM; Abramian A; Fleming J; Zhang W; Breslin T; Abbruzzese JL; Evans DB
Ann N Y Acad Sci; 1999 Jun; 880():31-7. PubMed ID: 10415848
[TBL] [Abstract][Full Text] [Related]
37. Differential expression of transforming growth factor beta receptors in human pancreatic adenocarcinoma.
Venkatasubbarao K; Ahmed MM; Mohiuddin M; Swiderski C; Lee E; Gower WR; Salhab KF; McGrath P; Strodel W; Freeman JW
Anticancer Res; 2000; 20(1A):43-51. PubMed ID: 10769633
[TBL] [Abstract][Full Text] [Related]
38. Loss of chromosome 18q and DPC4 (Smad4) mutations in appendiceal adenocarcinomas.
Maru D; Wu TT; Canada A; Houlihan PS; Hamilton SR; Rashid A
Oncogene; 2004 Jan; 23(3):859-64. PubMed ID: 14647445
[TBL] [Abstract][Full Text] [Related]
39. High-throughput drug screening of the DPC4 tumor-suppressor pathway in human pancreatic cancer cells.
Sohn TA; Su GH; Ryu B; Yeo CJ; Kern SE
Ann Surg; 2001 May; 233(5):696-703. PubMed ID: 11323508
[TBL] [Abstract][Full Text] [Related]
40. Smad4/DPC4-mediated tumor suppression through suppression of angiogenesis.
Schwarte-Waldhoff I; Volpert OV; Bouck NP; Sipos B; Hahn SA; Klein-Scory S; Lüttges J; Klöppel G; Graeven U; Eilert-Micus C; Hintelmann A; Schmiegel W
Proc Natl Acad Sci U S A; 2000 Aug; 97(17):9624-9. PubMed ID: 10944227
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
